These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 19058529
21. [Contraception--methods of preventing unintended pregnancy. Part II. Medical (artificial) methods of preventing an unintended pregnancy]. Debski R. Ginekol Pol; 2007 Nov; 78(11):834-41. PubMed ID: 18306912 [Abstract] [Full Text] [Related]
23. Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive. Roumen FJ, Dieben TO. Fertil Steril; 2006 Jan; 85(1):57-62. PubMed ID: 16412731 [Abstract] [Full Text] [Related]
24. Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen. Weisberg E, Merki-Feld GS, McGeechan K, Fraser IS. Contraception; 2015 Feb; 91(2):121-6. PubMed ID: 25459098 [Abstract] [Full Text] [Related]
25. The contraceptive vaginal ring, NuvaRing(®), a decade after its introduction. Roumen FJ, Mishell DR. Eur J Contracept Reprod Health Care; 2012 Dec; 17(6):415-27. PubMed ID: 23113828 [Abstract] [Full Text] [Related]
26. Lower hormone dosage with improved cycle control. Vree M. Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():25-30; discussion 37-9. PubMed ID: 12659399 [Abstract] [Full Text] [Related]
27. Residual hormone levels in used contraceptive rings as a measurement of adherence to vaginal ring use. Haaland RE, Holder A, Evans-Strickfaden T, Nyagol B, Makanga M, Oyaro B, Humwa F, Williams T, McLellan-Lemal E, Desai M, Huey MJ. Contraception; 2017 Jun; 95(6):602-604. PubMed ID: 28372978 [Abstract] [Full Text] [Related]
28. Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial. Oddsson K, Leifels-Fischer B, de Melo NR, Wiel-Masson D, Benedetto C, Verhoeven CH, Dieben TO. Contraception; 2005 Mar; 71(3):176-82. PubMed ID: 15722066 [Abstract] [Full Text] [Related]
30. The combined vaginal contraceptive ring, nuvaring, and cerebral venous sinus thrombosis: a case report and review of the literature. Kolacki C, Rocco V. J Emerg Med; 2012 Apr; 42(4):413-6. PubMed ID: 21945504 [Abstract] [Full Text] [Related]
33. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone. Milsom I, Lete I, Bjertnaes A, Rokstad K, Lindh I, Gruber CJ, Birkhäuser MH, Aubeny E, Knudsen T, Bastianelli C. Hum Reprod; 2006 Sep; 21(9):2304-11. PubMed ID: 16763008 [Abstract] [Full Text] [Related]
34. [ The statement of Polish Gynecological Society experts about using natural methods of preventing an unintended pregnancy]. Szamatowicz M, Karowicz-Bilińska A, Kotarski J, Nowak-Markwitz E, Oszukowski P, Poreba R, Rechberger T, Spaczyński M, Zespół Ekspertów Polskiego Towarzystwa Ginekologicznego w składzie. Ginekol Pol; 2010 Dec; 81(12):947-9. PubMed ID: 21395088 [No Abstract] [Full Text] [Related]
36. [Vaginal combined contraception NuvaRing in the clinical practice in the Czech Republic]. Fait T. Ceska Gynekol; 2009 Aug; 74(4):286-91. PubMed ID: 20564984 [Abstract] [Full Text] [Related]